Risk indicators and effects of hypertension on HIV/AIDS disease progression among patients seen at Kenyatta hospital HIV care center

References

• Aberg, J. A. (2012). Aging, inflammation, and HIV infection. Topics in Antiviral Medicine, 20(3), 101–105.
   PubMedGoogle Scholar
• Bloomfield, G. S., Hogan, J. W., Keter, A., Sang, E., Carter, E. J., Velazquez, E. J., & Kimaiyo, S. (2011). Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS One, 6(7), e22288. doi: 10.1371/journal.pone.0022288
   PubMed Web of Science ®Google Scholar
• Calo, L. A., Caielli, P., Maiolino, G., & Rossi, G. (2013). Arterial hypertension and cardiovascular risk in HIV-infected patients. Journal of Cardiovascular Medicine, 14(8), 553–558. doi: 10.2459/JCM.0b013e3283621f01
   PubMed Web of Science ®Google Scholar
• Calvo, M., & Martinez, E. (2014). Update on metabolic issues in HIV patients. Current Opinion in HIV and AIDS, 9(4), 332–339. doi: 10.1097/coh.0000000000000075
   PubMed Web of Science ®Google Scholar
• Calvo-Sanchez, M., Perello, R., Perez, I., Mateo, M. G., Junyent, M., Laguno, M., … Martinez, E. (2013). Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: Two parallel case-control studies. HIV Medicine, 14(1), 40–48. doi: 10.1111/j.1468-1293.2012.01057.x
   PubMed Web of Science ®Google Scholar
• Hasse, B., Bernasconi, E., Furrer, H., Eyer, M. M., & Kovari, H. (2014). [HIV-associated non-AIDS conditions]. Therapeutische Umschau, 71(8), 483–489. doi: 10.1024/0040-5930/a000541
   PubMedGoogle Scholar
• Hasse, B., Ledergerber, B., Furrer, H., Battegay, M., Hirschel, B., Cavassini, M., … Weber, R. (2011). Morbidity and aging in HIV-infected persons: The Swiss HIV cohort study. Clinical Infectious Diseases, 53(11), 1130–1139. doi: 10.1093/cid/cir626
   PubMed Web of Science ®Google Scholar
• Hernandez, S., Vidal, M., & Pedrol, E. (2009). [Cardiovascular risk assessment and intervention in HIV-infected patients]. Enfermedades Infecciosas y Microbiología Clínica, 27(Suppl 1), 40–47. doi: 10.1016/s0213-005x(09)73444-5
   PubMedGoogle Scholar
• Jarrett, O. D., Wanke, C. A., Ruthazer, R., Bica, I., Isaac, R., & Knox, T. A. (2013). Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus. AIDS Patient Care and STDs, 27(5), 266–271. doi: 10.1089/apc.2012.0402
   PubMed Web of Science ®Google Scholar
• Kavishe, B., Biraro, S., Baisley, K., Vanobberghen, F., Kapiga, S., Munderi, P., … Grosskurth, H. (2015). High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): A population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Medicine, 13, 1243. doi: 10.1186/s12916-015-0357-9
   Web of Science ®Google Scholar
• Khang, Y. H. (2013). Burden of noncommunicable diseases and national strategies to control them in Korea. Journal of Preventive Medicine & Public Health, 46(4), 155–164. doi: 10.3961/jpmph.2013.46.4.155
   PubMedGoogle Scholar
• Lopez-Jaramillo, P., Velandia-Carrillo, C., Alvarez-Camacho, J., Cohen, D. D., Sanchez-Solano, T., & Castillo-Lopez, G. (2013). Inflammation and hypertension: Are there regional differences? International Journal of Hypertension, 2013, 1–12. doi: 10.1155/2013/492094
   Google Scholar
• Malaza, A., Mossong, J., Barnighausen, T., Viljoen, J., & Newell, M. L. (2013). Population-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverage. PLoS One, 8(7), e70126. doi: 10.1371/journal.pone.0070126
   PubMed Web of Science ®Google Scholar
• Martin-Iguacel, R., Llibre, J. M., & Friis-Moller, N. (2015). Risk of cardiovascular disease in an aging HIV population: Where are we now? Current HIV/AIDS Reports, 12(4), 375–387. doi: 10.1007/s11904-015-0284-6
   PubMed Web of Science ®Google Scholar
• Martin-Iguacel, R., Negredo, E., Peck, R., & Friis-Moller, N. (2016). Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV. Current Hypertension Reports, 18(6), 2745. doi: 10.1007/s11906-016-0656-3
   Web of Science ®Google Scholar
• Masia, M., Padilla, S., Alvarez, D., Lopez, J. C., Santos, I., Soriano, V., … Gutierrez, F. (2013). Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: Role of antiretroviral therapy. AIDS, 27(2), 181–189. doi: 10.1097/QAD.0b013e32835a1156
   PubMed Web of Science ®Google Scholar
• Muhammad, S., Sani, M. U., & Okeahialam, B. N. (2013). Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy. Nigerian Medical Journal, 54(3), 185–190. doi: 10.4103/0300-1652.114591
   PubMedGoogle Scholar
• Nuesch, R., Wang, Q., Elzi, L., Bernasconi, E., Weber, R., Cavassini, M., … Bucher, H. C. (2013). Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV cohort study (SHCS). JAIDS Journal of Acquired Immune Deficiency Syndromes, 62(4), 396–404. doi: 10.1097/QAI.0b013e3182847cd0
   PubMed Web of Science ®Google Scholar
• Ogunmola, O. J., Oladosu, O. Y., & Olamoyegun, A. M. (2014). Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: A cross-sectional cohort study. Vascular Health and Risk Management, 10, 129–137. doi: 10.2147/vhrm.s58449
   PubMedGoogle Scholar
• Peck, R. N., Shedafa, R., Kalluvya, S., Downs, J. A., Todd, J., Suthanthiran, M., … Kataraihya, J. B. (2014). Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: A cross-sectional study. BMC Medicine, 12, 2224. doi: 10.1186/s12916-014-0125-2
   Web of Science ®Google Scholar
• Peters, B., Post, F., Wierzbicki, A. S., Phillips, A., Power, L., Das, S., … Di Angelantonio, E. (2013). Screening for chronic comorbid diseases in people with HIV: The need for a strategic approach. HIV Medicine, 14(Suppl 1), 1–11. doi: 10.1111/j.1468-1293.2012.01055.x
   PubMed Web of Science ®Google Scholar
• Spoulou, V., Kanaka-Gantenbein, C., Bathrellou, I., Mora, S., Mostrou, G., Sidossis, L., … Theodoridou, M. (2011). Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy. HORMONES, 10(2), 149–155. doi: 10.14310/horm.2002.1305
   PubMedGoogle Scholar
• Syed, F. F., & Sani, M. U. (2013). Recent advances in HIV-associated cardiovascular diseases in Africa. Heart (British Cardiac Society), 99(16), 1146–1153. doi: 10.1136/heartjnl-2012-303177
   PubMed Web of Science ®Google Scholar
• Willig, A. L., & Overton, E. T. (2014). Metabolic consequences of HIV: Pathogenic insights. Current HIV/AIDS Reports, 11(1), 35–44. doi: 10.1007/s11904-013-0191-7
   PubMed Web of Science ®Google Scholar
• Zhou, J., Lurie, M. N., Barnighausen, T., McGarvey, S. T., Newell, M. L., & Tanser, F. (2012). Determinants and spatial patterns of adult overweight and hypertension in a high HIV prevalence rural South African population. Health & Place, 18(6), 1300–1306. doi: 10.1016/j.healthplace.2012.09.001
   PubMed Web of Science ®Google Scholar